Breast Cancer Clinical Trial

Breast Cancer Biomarker Sample Collection for the dtectDx v2 Assay Proof of Concept Protocol

Summary

The major purpose of this study is to evaluate a laboratory developed test that measures multiple breast cancer-specific biomarker proteins and multiple antibodies in your blood samples. The biomarker and antibody results along with your personal medical profile will be evaluated to determine your risk for the presence of a malignancy in the breast as compared to your breast evaluation assessment conducted by your physician.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Adult women from 25 years of age to below 75 years of age
Breast evaluation results of ACR BI-RADS® Category 3 or 4 by imaging and physicians clinical and radiological evaluation
Study visit and blood collection within 4 weeks (28 days) of ACR BI-RADS assessment
Patient agrees to with additional health data being gathered at 6 months post assessment for diagnostic follow-up
Samples collected under IRB approval and Informed Consent
Testing performed under IRB approval or waiver (as applicable)
Previous approved procedures to enroll patients: breast augmentation & cyst aspiration

Exclusion Criteria:

Adults from 76 years of age or older and below 25 years of age
Final breast evaluation results other than a ACR BI-RADS Category 3 or 4
Subjects that have had a breast biopsy performed during the 6 months prior to the study visit
Samples not collected under IRB approval and Informed Consent
Testing not performed under IRB approval or waiver (as applicable)
Prior breast cancer diagnosis.

Study is for people with:

Breast Cancer

Estimated Enrollment:

500

Study ID:

NCT02078570

Recruitment Status:

Unknown status

Sponsor:

Provista Diagnostics, Inc

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 12 Locations for this study

See Locations Near You

St. Joseph's Hospital & Medical Center
Phoenix Arizona, 85013, United States
Mayo Clinic
Scottsdale Arizona, 85259, United States
Sutter Institute
Sacramento California, 95816, United States
Scripps
San Diego California, 92103, United States
Henry Ford Hospital
Detroit Michigan, 48202, United States
Sinai Grace
Detroit Michigan, 48235, United States
Mayo Clinic - Rochester
Rochester Minnesota, 55095, United States
Summit Medical Group Breast Center New Jersey
Berkeley Heights New Jersey, 07922, United States
Cleveland Clinic
Cleveland Ohio, 44195, United States
Mercy Womens Center
Oklahoma City Oklahoma, 73120, United States
Rhode Island Hospital
Providence Rhode Island, 02903, United States
Avera Research Institute
Sioux Falls South Dakota, 57105, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

500

Study ID:

NCT02078570

Recruitment Status:

Unknown status

Sponsor:


Provista Diagnostics, Inc

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider